Harald F. Stock, PhD.
Chief Executive Officer
Harald F. Stock was born in Freiburg / Breisgau in 1968. He studied Chemistry and Business Administration in the USA, Great Britain and Germany and received a PhD. in inorganic chemistry from the University of Heidelberg in 1997. He started his career in Health Care as a Key Account Manager at Hestia Pharma. Thereafter he held various positions of increasing responsibilities in local and global functions and corporate divisions of the Roche Group, until in 2005 he was appointed Senior Vice President of the global Near Patient Testing business in Graz.
Before joining Grünenthal, from 2006 until the end of 2008 he was Chairman and Managing Director of the German DePuy Group, the Orthopaedics Division of Johnson&Johnson. Between April and December 2008, he in addition represented Johnson&Johnson on the Board of BVMed, the German Medical Technology Industry Association. In January 2009 he was appointed Chief Executive Officer of the Grünenthal Group. Harald F. Stock was appointed Member of the Board for immatics biotechnologies GmbH, Tübingen, Germany, in February 2011. From May 2011 to October 2012, he was the Vice-chairman of the Supervisory Board of PAION AG, a biopharmaceutical company headquartered in Aachen, Germany. In February 2013, he was appointed to the Board of Directors of the life science company OvaScienceSM. Harald F. Stock is a Board Member at the European Federation of Pharmaceutical Industries and Associations (efpia).